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Streptococcus pneumoniae is part of the normal bacterial flora of the narsopharynx, but
is also associated with several invasive and non-invasive diseases. Recently, there has
been a plethora of research information on the pneumococcus, however, there are few
comprehensive review papers discussing the research information. This paper provides a
review of the pneumococcus in two vital areas related to its biology including transmission
and evolution. Transmission of the pneumococcus is a highly efficient process that usually
occurs through respiratory droplets from asymptomatic carriers. Following acquisition, the
pneumococcus may only establish in the nasopharynx of the new host, or further progress
to sites such as the lungs and cause disease. Pneumococcus transmission risk factors, as
well as factors involved in its translocation from the nasophyarnx to diseases sites are
still not fully understood. Pneumococcal evolution is dominated by recombination. The
recombinational events usually involve genetic exchange with streptococci of the mitis
group and some pneumococci are thought to exhibit hyper-recombination.
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INTRODUCTION
The pneumococcus is one of the most virulent human pathogens
and causes a wide range of infections, including invasive and non-
invasive diseases. There are about one million new pneumococcal
infections every year, majority of which occur among children<5
years, and the organism is responsible for 10–20% of all deaths
in this age group (O’Brien et al., 2009). Until about two decade
ago, little was known about Streptococcus pneumoniae. However,
since this time there has been a plethora of research informa-
tion contributing significantly to our understanding about this
very important human pathogen. Unfortunately, there are few
recent comprehensive review papers discussing the plethora of
research information about the pneumococcus. This paper pro-
vides a review of the pneumococcus in two vital areas related to
its biology including transmission and evolution.
S. pneumoniae CARRIAGE AND DISEASES
S. pneumoniae is part of the normal bacterial flora of the upper
respiratory tract of humans, and is mainly found in the nasophar-
ynx. Carriage of the organism is more prevalent in children than
adults; the colonization rate rises from birth until it peaks around
the age of 1–2 years, and thereafter an age related decline is
observed (Lloyd-Evans et al., 1996; Hussain et al., 2005). S. pneu-
moniae carriage normally lasts for a couple of weeks, and duration
periods of more than 30 weeks are observed (Sleeman et al., 2008).
A seasonal carriage trend has also been described, with peak rates
occurring during January–March (Gray et al., 1980). Children
acquire several different strains over time, and less immunogenic
serotypes tend to be carried in the narsopharynx for a much
longer period of time than the more immunogenic serotypes
(Rosen et al., 1984; Obaro and Adegbola, 2002).
In developing countries, carriage rates are relatively higher
especially, in children. In the Gambia, Lloyd-Evans et al. (1996)
reported a carriage rate of 80% among children under five years of
age, and a lower rate of 20% in adults. In a study by Gratten et al.
(1986), it was found that 60% of infants in Papua New Guinea
acquired S. pneumoniae already during the neonatal period, and
all infants were colonized within the first 3months of life (Gratten
et al., 1986). Similar high S. pneumoniae carriage rates in the
developing world have been reported in several other countries
including Zambia (Frederiksen and Henrichsen, 1988), Pakistan
(Mastro et al., 1993), The Philippines (Lankinen et al., 1994),
Papua NewGuinea (Gratten et al., 1986), and Bangladesh (Granat
et al., 2007). In the developed world, S. pneumoniae carriage
appears to be lower than rates found in the developing world.
Aniasson et al. (1992) reported that in Sweden, only 12% of
infants were colonized with S. pneumoniae at 3 months, 30% at
7 months, and 32% at 12–18 months. In the UK, a longitudinal
study by Goldblatt et al. (2005) showed an overall prevalence rate
of 25%, with carriage rates of 52 and 8% in children under 2 years
and adults over 18 years of age, respectively. Labout et al. (2008)
studied S. pneumoniae carriage in infants in the Netherlands
and observed carriage rates of 8.3% at age 1.5 months, 31.3%
at 6 months, and 44.5% at 14 months. The high pneumococcal
carriage rates in the developing world appear to provide more
opportunities for multiple carriage, as relatively higher multiple
carriage rates have also been reported in the developing countries
compared to the developing world (Gratten et al., 1994; Obaro
et al., 1996; Brugger et al., 2010).
The major diseases caused by S. pneumoniae include pneu-
monia, meningitis, septicaemia, and otitis media. There are two
types of pneumonia, namely, bronchial pneumonia and lobar
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pneumonia, and S. pneumoniae is a major cause of both types. In
an infection of pneumonia, S. pneumoniae stimulates the immune
system and causes migration of white blood cells to the lungs. The
interaction of white blood cells, proliferating bacteria and exces-
sive fluid define the presence of pneumonia (Tuomanen et al.,
1995), which can be detected by a chest X-ray. Bacteraemia and
septicaemia can occur in 20–30% of cases with pneumococcal
pneumonia (Musher, 2004). S. pneumoniae meningitis perhaps
has the highest case fatality rate (∼40%) among the various
pneumococcal infections and up to 50% of survivors suffer from
debilitating sequalae such as mental retardation and motor defi-
ciency (Bohr et al., 1984; Leimkugel et al., 2005). The clinical
presentations of meningitis caused by S. pneumoniae are similar
to other bacterial causes of acute meningitis and include severe
headache, photophobia, neck stiffness, and fever. Otitis media is
the most common of the pneumococcal diseases. The condition
is an inflammation of the middle ear and up to 50% of the cases
are caused by S. pneumoniae (Musher, 2004). The major clini-
cal signs of the infection include limited mobility and enlarged
tympanic membrane. It is reported that successful treatment with
antibiotics can still lead to recurrent otitis media due to proxim-
ity of the middle ear to the nasopharynx where S. pneumoniae
resides (Libson et al., 2005). Other S. pneumoniae diseases include
conjunctivitis, acute tracheobronchitis, endometritis, peritonitis,
endocarditis, arthritis, and osteomyelitis. However, these infec-
tions are relatively uncommon.
TRANSMISSION OF S. pneumoniae
As humans are the main host for S. pneumoniae, successful trans-
mission of S. pneumoniae among humans is crucial for survival
of the organism, and without this the pneumococcus is likely
to be eliminated. Transmission of S. pneumoniae occurs through
respiratory droplets from people with pneumococcal disease or
more commonly healthy individuals who carry the organism in
the nasopharynx (Bogaert et al., 2004; Sleeman et al., 2005). Little
is known about the risk factors of pneumococcal transmission,
though certain risk factors including number of siblings and vis-
its to general practitioners for mild upper respiratory disease
have been identified (Sleeman et al., 2005). Additionally, higher
rates of pneumococcal transmission are known to occur at cer-
tain sites including day care centers, military camps, and prisons
(Givon-Lavi et al., 2002; Bogaert et al., 2004). Givon-Lavi et al.
(2002) compared pneumococcal isolates recovered from children
in day care centers with isolates recovered from younger siblings
not attending day care by pulsed-field gel electrophoresis. This
showed a high level of genetic similarity among isolates from the
specific day care center the older sibling was attending and those
isolated from younger siblings, which indicate that pneumococcal
transmission may be a highly efficient process.
Following acquisition, the pneumococcus may establish in
the nasopharynx of the new host, and in most cases this leads
to asymptomatic colonization (Sleeman et al., 2008). However,
occasionally, the newly acquired pneumococcus moves from the
nasopharynx to other parts of the human host such as the
lungs where it evades the host defence mechanisms and causes
disease (Bogaert et al., 2004). Because asymptomatic carriers
far exceed symptomatic individuals, most of the links in the
transmission chain of person-to-person are not visible. In con-
trast, a respiratory disease such as measles is also transmitted
person-to-person through the same route as pneumococcus but
asymptomatic colonization does not happen, and each link in
the transmission chain is evident as disease (Mrozek-Budzyn,
2010). There is evidence that the risk for progression of pneu-
mococcus from asymptomatic colonization to disease seems to
be greatest soon after acquisition and a complex interplay of fac-
tors are involved (Sleeman et al., 2005). Colonizing pneumococci
strains may elicit an immune response that may eliminate them
(Obaro and Adegbola, 2002). Additionally, the composition of
the microflora of the nasopharynx, which is thought to contain
more than 700 diverse species, may support or hinder coloniza-
tion and invasion by symbiosis and/or competition (Aniasson
et al., 1992; Harputluoglu et al., 2005). There are significant differ-
ences in the attack rate of different serotypes, where attack rates
refer to the incidence of invasive pneumococcal disease per the
incidence of pneumococcal acquisition. Pneumococcal serotypes
such as 1, 4, 5, and 9A have high attack rates, while serotypes
such as 9N, 16F, 20, and 38 have low attack rates; generally, attack
rates are higher for serotypes which are carried for short time
periods (Sleeman et al., 2005). Phase variation where pneumo-
coccal variants have the same serotype but vary from opaque to
transparent colonies, is thought to be important in the progres-
sion of S. pneumoniae from carriage to invasive disease (Weiser
et al., 1994; Arai et al., 2011). This is because the opaque form
has been commonly isolated from patient samples, while the
transparent form is adapted to colonization of the nasopharynx.
According to Ring et al. (1998), phase variation of the trans-
parent type increases pneumococcal invasion into human brain
microvascular endothelial cells as much as six-fold.
EVOLUTION OF S. pneumoniae
Evolution of the pneumococcal population is known to be dom-
inated by recombination. Using MLST data, Feil et al. (2000)
demonstrated that the rate of recombination in S. pneumoniae
was 10 times higher than the rate of mutation, while for Neisseria
meningitidis, the rate of mutation was five times higher than the
rate of mutation. The high rate of pneumococcal recombination
has recently been illustrated by the whole genome sequencing of
240 strains of a single lineage, ST 81 (Croucher et al., 2011a).
This showed that over 700 recombinational events had occurred
in this pneumococcal lineage and 74% of the genome length had
undergone recombination in at least one isolate. Currently, it is
unknown whether this observation holds for all pneumococcal
lineages or whether certain geographical settings could lead to
yet more recombination. In contrast to the frequent pneumo-
coccal recombination, mutation is known to be more impor-
tant than recombination in evolution of clonal bacteria such as
Staphylococcus aureus (Feil et al., 2003). The high rates of pneu-
mococcal recombination may be attributed to the relatively high
density of repeat elements in the genome that may facilitate incor-
poration of foreign DNA into the S. pneumoniae chromosome
and contribute to rearranging its structure. Aras et al. (2003)
analysed the density of repeats for 51 prokaryotic genomes, and
observed that S. pneumoniae had the greatest density of 1 every
500 bp. Until recently, two types of such repeat elements including
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BOX and RUPS elements were known to occur in the S. pneu-
moniae genome. However, a study by Croucher et al. (2011b)
identified a third type of repeat element called Streptococcus pneu-
moniae Rho-independent Terminator-like Element (SPITE). Like
the previously known BOX and RUPS repeat elements, SPRITE is
thought to contribute to genome evolution of the pneumococcus
and is important in termination of transcription (Croucher et al.,
2011b). Another factor that contributes to the high S. pneumoniae
recombination is the fact that the pan-genome of the organism is
open which means that the pan-genome has an infinite size and
thus provides a rapid response to diverse environments (Donati
et al., 2010). Phylogenetic studies on S. pneumoniae have shown
that, the high rates of recombination can result in the elimination
of any deep-rooted phylogenetic signal (Feil and Spratt, 2001).
However, this does not prevent the formation of distinct pneumo-
coccal lineages or clones but makes such clones relatively unstable
compared to several other bacteria (Feil et al., 2003; Donati et al.,
2010).
S. pneumoniae interspecies recombination is usually related to
genetic exchange with streptococci of the mitis group (Hanage
et al., 2009). The mitis group of streptococci currently includes S.
pneumoniae and 10 other members: S. oralis, S. mitis, S. infantis,
S. sanguis, S. gordonii, S. pseudopneumoniae, S. cristatus, S.
oligofermentans, S. parasanguinis, and S. peroris. S. pneumoniae
which is the main pathogen in the group is closely related to S.
oralis, and both species are believed to have evolved from a com-
mon ancestor (Kilian et al., 2008). Genetic exchange between S.
pneumoniae and other mitis streptococci is facilitated by the co-
habitation of these organisms in the nasopharynx, as well as the
natural transformability of S. pneumoniae (Kilian et al., 2008).
Based on sequence analysis of pbp genes, S. mitis and S. oralis have
been found to donors of chromosomal DNA to S. pneumoniae in
the evolution of mosaic penicillin-binding protein genes (Zerfass
et al., 2009). Such mosaic pneumococcal genes from homologous
recombination with the mitis group streptococci have also been
observed in virulence genes such as lytA, nanA, pspA, and pspC
(Johnston et al., 2010). Using MLST data, Hanage et al. (2009)
investigated recombination among S. pneumoniae and other mitis
group streptococci, and observed a distinct population of S. pneu-
moniae that exhibit hyper-recombination (Figure 1). This pneu-
mococcal sub-population which was the main recipient of genetic
material from other mitis group streptococci showed signifi-
cantly higher levels of resistance for various antibiotics (penicillin,
erythromycin, tetracycline, chloramphenicol, and cefotaxime)
compared to other pneumococcal sub-populations which did
not show evidence of recombination. While the basis of such a
FIGURE 1 | (A) Admixture analysis of 2024 distinct streptococcal
genotypes of S. pneumoniae, S. oralis, S. mitis, and S. pseudopneumoniae
based on Bayesian Analysis of Population Structure. (B) Minimum evolution
tree constructed from concatenates of the different streptococci species.
The streptococci fell into six clusters shown by the different colors
(coloring of taxa in B corresponds to colors of BAPS clusters in A).
Three BAPS clusters (including Clusters 1, 2, and 4) were associated
with S. pneumoniae subpopulations, while the other three BAPS
clusters namely, clusters 3, 5, and 6 were associated with S. mitis, S.
pseudopneumoniae, and S. oralis, respectively. Relatively, S. pneumoniae
cluster 4 appears heterogeneous and the isolates of this BAPS cluster are
composed of a high proportion of mosaics due to genetic material from
other clusters of S. pneumoniae and other streptococci. Adapted from
Hanage et al. (2009).
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pneumococcal population exhibiting hyper-recombination is
poorly understood, in terms of genome evolution, it is possible
that the population may possess extraordinarily high density of
repeat elements (Hoskins et al., 2001; Tettelin et al., 2001). Defects
in the DNA mismatch repair system may also contribute to
the hyper-recombination of this pneumococcal sub-population
(Denamur and Matic, 2006; Hall and Henderson-Begg, 2006;
Henderson-Begg et al., 2010). Very recently, Croucher et al.
(2012) have demonstrated that the location and selective advan-
tage of accessory genome loci may have the greatest mechanistic
impact on homologous recombination occurring between lin-
eages of the pneumococcal species. While there is a distinct pneu-
mococcal population that exhibit hyper-recombination, there is
no evidence of a pneumococcal population that exhibit hyper-
mutation (Henderson-Begg et al., 2010).
Pneumococcal evolutionary events frequently occur at the
capsular locus (cps), which encodes the pneumococcal capsule.
The pneumococcal cps genes are flanked by the conserved dexB
and aliA genes and synthesize capsule polysaccharide via the
Wzx/Wzy-dependent pathway using the regulatory and process-
ing genes wzg, wzh, wzd, and wze (Kolkman et al., 1998; Garcia
et al., 2000). The only exceptions are serotypes 3 and 37 which
utilize a synthase pathway for capsular biosynthesis (Cartee et al.,
2001; Llull et al., 2001). Homologous recombination occurs at
the flanking regions common among different serotypes. Each
pneumococcal cps has a serotype specific region, where recom-
binational events lead to capsular switching and the possible
formation of vaccine escape variants (Golubchik et al., 2012).
Additionally, capsular recombinational events resulting in some
pneumococcal capsular types may be associated with increase in
virulence (Hu et al., 2012). It appears that some capsular genes
undergo recombinational exchange among pneumococcal lin-
eages more commonly than others. Several reasons may account
for this observation, including differences in the genetic organi-
zation within the capsular loci (Bentley et al., 2006), the capabil-
ities of the pneumococcal isolates to be transformed (Chen and
Dubnau, 2004), and co-existence of isolates of different pneumo-
coccal serotypes in the nasophyarnx. Within the pneumococcal
cps loci, several mutational events have also been documented
(Bentley et al., 2006), with some recent data suggesting that muta-
tional events are also important in capsular switching (Sheppard
et al., 2010).
CONCLUSIONS
Transmission of the pneumococcus is a highly efficient pro-
cess that usually occurs through respiratory droplets from
asymptomatic carriers. Following acquisition, the pneumococ-
cus may only establish in the nasopharynx of the new host,
or further progress to sites such as the lungs and cause dis-
ease. Pneumococcus transmission risk factors, as well as factors
involved in its translocation from the nasophyarnx to diseases
sites are still not fully understood. Pneumococcal evolution is
dominated by recombination which may be attributed to the rel-
atively high density of repeat elements in the genome and also the
fact that the pan-genome of the organism is open. The recombi-
national events usually involve genetic exchange with streptococci
of the mitis group and some pneumococci are thought to exhibit
hyper-recombination.
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